| 摘要 |
FIELD: medicine, pharmacy. SUBSTANCE: composition has a glucagon-like peptide and its derivatives and is able to stimulate synthesis and expression of hormone insulin. Composition shows insulinotropic activity and can be used for treatment of patients with noninsulin dependent diabetes mellitus. EFFECT: enhanced effectiveness of a composition. 7 cl, 10 dwg, 10 tbl, 47 ex
|
